Le Lézard
Classified in: Business
Subject: STH

IIROC Trading Halt - DEV.H


VANCOUVER, BC, Oct. 26, 2020 /CNW/ - The following issues have been halted by IIROC:

Company: CT Developers Ltd.

TSX-Venture Symbol: DEV.H

All Issues: No

Reason: At the Request of the Company Pending News

Halt Time (ET): 2:26 PM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions


These press releases may also interest you

at 16:05
Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced financial results for the full year ended December 31, 2023, and provided an overview of recent developments....

at 16:05
Danimer Scientific, Inc. ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its fourth quarter and full year, ended...

at 16:05
EACO Corporation today reported the results for its quarter ended February 29, 2024. Net sales, net income and earnings per share were as follows for the three months ended February 29, 2024 (dollars in thousands, except per share information):...

at 16:05
CVD Equipment Corporation , today announced its financial results for the fourth quarter and fiscal year ended December 31, 2023. Manny Lakios, President and CEO of CVD Equipment Corporation, commented, "Fourth quarter 2023 revenue was $4.1...

at 16:05
Leafly Holdings, Inc. ("Leafly" or "the Company") , a leading online cannabis discovery marketplace and resource for cannabis consumers, today announced financial results for its fourth quarter and year ended December 31, 2023. "We saw continued...

at 16:05
Helius Medical Technologies, Inc. ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced results for the quarter and full year ended December...



News published on and distributed by: